{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid7ykiwpwbbdwmjpzspmpsfooqnvnpqu66ypz4epbusnprckfg67u",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3mfgpsccbryl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihwzvspt4qexuynjnxjvquwwbia4yiz6set64ulml7qleoinvvgpm"
    },
    "mimeType": "image/gif",
    "size": 6057041
  },
  "path": "/article/an-alphafold-4-scientists-marvel-at-deepmind-drug-spin-offs-exclusive-new-ai/",
  "publishedAt": "2026-02-21T13:00:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results",
  "title": "‘An AlphaFold 4’—scientists marvel at DeepMind drug spin-off’s exclusive new AI"
}